-
-
-
-
-
-
-
Genmab A/S (GMAB) Reports FY EPS of $15.37
-
-
-
-
-
-
-
Genmab A/S (GMAB) PT Lowered to $27 at Leerink Partners
-
-
-
-
-
-
-
Genmab Completes Acquisition of ProfoundBio
-
-
-
-
-
-
-
BMO Capital Upgrades Genmab A/S (GMAB) to Outperform 'On Improved Outlook ex-Darzalex, Pipeline Optionality'
-
-
-
-
-
-
-
Genmab Announces Financial Results for the First Quarter of 2023
-
-
-
-
-
-
-
Genmab Announces Financial Results for the First Nine Months of 2021
-
-
-
-
-
-
-
Genmab Announces Financial Results for the First Nine Months of 2020
-
1,238,104 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


